Imatinib mesilate
REF : Y0001691
Descrição :Imatinib mesilate European Pharmacopoeia (EP) Reference Standard
Clique para mais informações
Clique para mais informações
Categoria : Selected Certified Reference Materials
Descrição detalhada : This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Sinónimos : Imatinib mesylate; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate; 4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide mesylate; CGP 57148; Genfatinib; Glivec; Imatinib methanesulfonate; STI-571
Fórmula molecula r: C29H31N7O · CH4O3S
Armazenamento : 2-8C
Embalagem : 1X1EA
Sinónimos : Imatinib mesylate; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate; 4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide mesylate; CGP 57148; Genfatinib; Glivec; Imatinib methanesulfonate; STI-571
Fórmula molecula r: C29H31N7O · CH4O3S
Armazenamento : 2-8C
Embalagem : 1X1EA